Cardiac a1-adrenergic drive in pathological remodelling
نویسندگان
چکیده
Cellular Biochemistry, Baker Heart Research Institute, Melbourne, Victoria 3004, Australia; Experimental Cardiology Laboratories, Baker Heart Research Institute, Melbourne, Victoria 3004, Australia; Molecular Cardiology and Biophysics Program, Victor Chang Cardiac Research Institute, Sydney, New South Wales 2010, Australia; and University of New South Wales, Kensington, New South Wales 2033, Australia
منابع مشابه
Constitutive glycogen synthase kinase-3α/β activity protects against chronic β-adrenergic remodelling of the heart
AIMS Glycogen synthase kinase 3 (GSK-3) signalling is implicated in the growth of the heart during development and in response to stress. However, its precise role remains unclear. We set out to characterize developmental growth and response to chronic isoproterenol (ISO) stress in knockin (KI) mice lacking the critical N-terminal serines, 21 of GSK-3alpha and 9 of GSK-3beta respectively, requi...
متن کاملOrphan nuclear receptor Nur77 affects cardiomyocyte calcium homeostasis and adverse cardiac remodelling
Distinct stressors may induce heart failure. As compensation, β-adrenergic stimulation enhances myocardial contractility by elevating cardiomyocyte intracellular Ca(2+) ([Ca(2+)]i). However, chronic β-adrenergic stimulation promotes adverse cardiac remodelling. Cardiac expression of nuclear receptor Nur77 is enhanced by β-adrenergic stimulation, but its role in cardiac remodelling is still uncl...
متن کاملRequisite Role of Cardiac Myocytes in Coronary a1-Adrenergic Constriction
Background—a-Adrenergic activation in vivo causes constriction of coronary arterioles, but, paradoxically, in vitro these microvessels do not contract to this stimulus. We hypothesized that cardiac myocytes have a requisite role in a1-adrenergic coronary arteriolar constriction through the release of myocyte-derived contractile factor(s). Methods and Results—Administration of the a1-adrenergic ...
متن کاملLisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart.
BACKGROUND In subjects with heart failure, angiotensin converting enzyme inhibitors exhibit mild systemic antiadrenergic effects, as deduced from treatment-related lowering of systemic venous norepinephrine levels. The effects of angiotensin converting enzyme inhibitors on cardiac adrenergic drive in subjects with heart failure has not previously been investigated. METHODS AND RESULTS In a pl...
متن کاملLoss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
AIMS Impaired Ca2 + cycling and myocyte contractility are a hallmark of heart failure triggered by pathological stress such as hemodynamic overload. The A-Kinase anchoring protein AKAP150 has been shown to coordinate key aspects of adrenergic regulation of Ca2+ cycling and excitation-contraction in cardiomyocytes. However, the role of the AKAP150 signalling complexes in the pathogenesis of hear...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008